|
|
|
Insider
Information: |
Wheeler Kurt |
Relationship: |
10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
8,638,466 |
|
Indirect Shares
|
50,230,112 |
|
|
Direct
Value |
$53,785,215 |
|
|
Indirect Value
|
$221,892,279 |
|
|
Total
Shares |
58,868,578 |
|
|
Total
Value |
$275,677,494 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
1
|
6
|
Stock
price went up :
|
1
|
6
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
1.0
|
6.0
|
Percentage
Gain/Loss : |
12.5%
|
44.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Rigel Pharmaceuticals Inc |
RIGL |
10% Owner |
2003-06-26 |
3,612,947 |
2004-09-13 |
475,026 |
Premium* |
|
Cyclacel Pharmaceuticals Inc |
CYCC |
10% Owner |
|
0 |
2004-03-16 |
87,899 |
Premium* |
|
Hemosense Inc |
HEM |
Director, 10% Owner |
2005-07-01 |
0 |
2007-11-06 |
0 |
Premium* |
|
American Cryostem Corporation |
CRYO |
Director, 10% Owner |
2005-07-13 |
0 |
2008-05-28 |
0 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director, 10% Owner |
2009-12-31 |
57,377 |
2009-12-31 |
4,632,562 |
Premium* |
|
Poniard Pharmaceuticals |
PARD |
10% Owner |
|
0 |
2009-11-09 |
6,363,249 |
Premium* |
|
Affymax Inc |
AFFY |
10% Owner |
|
0 |
2006-12-20 |
1,600,469 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
10% Owner |
2007-05-30 |
0 |
2007-05-30 |
2,987,769 |
Premium* |
|
Ithaka Acquisition Corp |
ITHKU |
Director, 10% Owner |
|
0 |
2007-06-21 |
2,672,568 |
Premium* |
|
Aryx Therapeutics Inc |
ARYX |
10% Owner |
2007-11-13 |
0 |
2008-11-14 |
5,364,572 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
|
0 |
2011-10-27 |
11,133,961 |
Premium* |
|
Aveo Pharmaceuticals Inc |
AVEO |
Former 10% Stockholder |
2010-03-17 |
0 |
2010-03-17 |
2,208,961 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
Director, 10% Owner |
2010-11-29 |
0 |
2010-11-29 |
5,982,439 |
Premium* |
|
Humanigen Inc |
HGEN |
10% Owner |
2013-02-05 |
0 |
2013-02-05 |
2,632,928 |
Premium* |
|
Aerie Pharmaceuticals Inc |
AERI |
10% Owner |
2015-01-28 |
0 |
2013-10-25 |
0 |
Premium* |
|
Oxford Immunotec Global Plc |
OXFD |
10% Owner |
2015-06-16 |
2,237,377 |
2013-11-22 |
0 |
Premium* |
|
Radius Health Inc. |
RDUS |
Former 10% stockholder |
2014-06-06 |
0 |
2016-09-27 |
2,459,804 |
Premium* |
|
Iveric Bio Inc |
ISEE |
10% Owner |
2015-05-26 |
0 |
2014-06-11 |
4,500 |
Premium* |
|
Sientra, Inc. |
SIEN |
10% Owner |
2014-10-28 |
2,730,765 |
|
0 |
Premium* |
|
Entasis Therapeutics Holdings Inc. |
ETTX |
10% Owner |
2018-09-28 |
0 |
2018-09-28 |
1,623,405 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
137 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-13 |
4 |
S |
$22.30 |
$223,000 |
I/I |
(10,000) |
1,824,423 |
|
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-09-26 |
4 |
S |
$1.11 |
$233,100 |
I/I |
(210,000) |
14,423,961 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-10 |
4 |
S |
$1.04 |
$239,200 |
I/I |
(230,000) |
13,338,529 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-24 |
4 |
S |
$1.03 |
$259,560 |
I/I |
(252,000) |
12,153,968 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-07 |
4 |
S |
$1.03 |
$283,456 |
I/I |
(275,200) |
13,568,529 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-17 |
4 |
S |
$22.44 |
$305,216 |
I/I |
(13,599) |
1,810,824 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-03-19 |
4 |
S |
$20.00 |
$346,680 |
I/I |
(17,334) |
4,150,571 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-04-30 |
4 |
AS |
$18.06 |
$352,221 |
I/I |
(19,500) |
3,465,269 |
0 |
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-06-11 |
4 |
S |
$14.27 |
$359,147 |
D/D |
(25,168) |
2,285,037 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-05-27 |
4 |
S |
$17.85 |
$359,672 |
I/I |
(20,154) |
3,506,943 |
|
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-03-18 |
4 |
S |
$14.68 |
$367,000 |
D/D |
(25,000) |
2,474,755 |
0 |
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-03-23 |
4 |
S |
$14.44 |
$379,772 |
D/D |
(26,300) |
2,371,328 |
0 |
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-03-20 |
4 |
S |
$14.53 |
$393,981 |
D/D |
(27,115) |
2,397,628 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-20 |
4 |
S |
$1.03 |
$437,750 |
I/I |
(425,000) |
12,476,068 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-06-22 |
4 |
S |
$15.51 |
$462,153 |
I/I |
(29,805) |
3,461,158 |
|
- |
|
CRYO |
American Cryostem Corpora... |
Director |
|
2007-04-24 |
4 |
B |
$5.14 |
$496,272 |
I/I |
96,551 |
3,028,082 |
2.25 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-04-19 |
4 |
S |
$20.30 |
$507,500 |
I/I |
(25,000) |
3,809,269 |
|
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-09-01 |
4 |
S |
$21.13 |
$517,719 |
I/I |
(24,500) |
1,687,072 |
|
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-06-16 |
4 |
S |
$14.30 |
$567,724 |
D/D |
(39,701) |
2,237,377 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
Director |
|
2007-05-01 |
4 |
AS |
$18.07 |
$576,968 |
I/I |
(31,925) |
3,433,344 |
0 |
- |
|
RIGL |
Rigel Pharmaceuticals Inc |
10% Owner |
|
2004-08-20 |
4 |
S |
$21.84 |
$600,619 |
I/I |
(27,499) |
1,772,925 |
|
- |
|
PARD |
Poniard Pharmaceuticals |
10% Owner |
|
2009-11-05 |
4 |
S |
$8.00 |
$626,292 |
I/I |
(78,262) |
6,779,949 |
0 |
- |
|
AERI |
Aerie Pharmaceuticals Inc |
10% Owner |
|
2015-01-05 |
4 |
S |
$30.67 |
$728,913 |
D/D |
(23,620) |
3,499,259 |
0 |
- |
|
OXFD |
Oxford Immunotec Global P... |
10% Owner |
|
2015-03-19 |
4 |
S |
$14.61 |
$730,675 |
D/D |
(50,012) |
2,424,743 |
0 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
10% Owner |
|
2011-10-27 |
4 |
S |
$1.03 |
$760,971 |
I/I |
(738,807) |
11,133,961 |
0 |
- |
|
137 Records found
|
|
Page 4 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|